It was reported that Cyclin A2 (CCNA2) was significantly overexpressed in various cancer types including ER+ breast cancer [33], splenic diffuse red pulp small B-cell lymphoma [34], rectal neuroendocrine tumors [35]. This evidence concerns the gene CCNA2 and breast cancer.